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Background: Although several potential etiologic factors associated with retrograde peri-implantitis (RPI)
and potential treatment options have been discussed in the literature, the etiology has not been fully investi-
gated and the definitive management methods remain undefined. We propose a decision-making protocol
for the treatment of RPI and provide new insight into the etiology of this process based on the findings from
two clinical cases.
Methods: The medical and dental histories of two patients who developed RPI were thoroughly reviewed.
Both patients were treated according to the treatment guidelines proposed in this manuscript. Fluid from the le-
sions was collected to examine the presence of 11 bacterial species by molecular-based microbial testing. Biop-
sies were also obtained for histopathologic examination.
Results: Patient 1, previously diagnosed with human immunodeficiency virus infection, developed RPI 3
months after implant placement. Histopathologic examination revealed a predominantly fibrous connective tis-
sue response with minimal inflammatory infiltrate and bone formation. Patient 2 presented histopathologically
with an intense acute inflammatory response. Eikenella corrodens was detected by microbial testing. Three
months after surgical intervention, both cases healed uneventfully, and the radiodensity in the lesions signifi-
cantly increased. The two implants are now functional and free of further complications.
Conclusions: The possible role of bacterial infection from an adjacent tooth may be a potential etiologic factor
in the development of RPI. In addition, HIV infection may be associated with RPI and deserves further investiga-
tion. A decision-making flowchart was proposed after critically evaluating the currently available relevant lit-
erature. Both cases presented in this manuscript were successfully treated by following this protocol. J
Periodontol 2011;82:1080-1088.
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etrograde peri-implantitis (RPI) is defined as
a clinically symptomatic periapical lesion (di-
agnosed as a radiolucency) that develops
shortly after implant insertion in which the coronal
portion of the implant achieves a normal bone–
implant interface.1 This condition was first described
by McAllister et al.2 in which microbial involvement
from the implant site, the extracted teeth or adjacent
teeth, generation of excess bone heat during implant
placement, and premature loading from inadequate
relief of interim prostheses were considered the pro-
bable causes. Other etiologic possibilities are sum-
marized in Table 1.2-10
The prevalence of RPI was assessed in a retrospec-
tive study of 539 implants, with 1.6% of maxillary and
2.7% of mandibular teeth exhibiting this condition be-
fore abutment connection.4 Endodontic periapical
pathology associated with either the previously ex-
tracted or neighboring teeth was present more often
(three times) in cases of peri-implantitis compared
to successfully integrated implants, suggesting that
endodontic pathology is the most likely primary eti-
ology. A recent article by Zhou et al.11 supports this
theory because their reported incidence of peri-
implantitis on implants adjacent to an endodontically
treated tooth was 7.8%, which is higher than the over-
all reported incidence.
Sussman12 proposed two pathways that may lead to
RPI: type 1 (implant to tooth) and type 2 (tooth to im-
plant). Type 1 RPI occurs when the osteotomy prepa-
ration causes direct or indirect damage to the adjacent
tooth, resulting in devitalization of the tooth pulp and
periapical pathology. Subsequently, the periapically
infected tooth inhibits osseointegration of the implant.
Type 2 RPI occurs when an adjacent tooth with periap-
ical pathology contaminates the fixture and interferes
with osseointegration of the implant.
Reiser and Nevins3 proposed an alternate RPI clas-
sification system, based on the presence or absence of
symptoms, as either inactive or infected lesions. The
inactive lesion may mimic a periapical scar at the root
apex and not present with clinical symptoms, whereas
the infected lesion is usually associated with pain, ten-
derness, fistula formation, or swelling.
Although there have been numerous reports that
have discussed the etiology and treatment of RPI
(Table 1), clinical decision-making guidelines are
still lacking. The aim of this article is to propose a
decision-making flowchart for the treatment of RPI
from critically evaluating different surgical modalities
based on evidence-based review. The histology, pos-




A 45-year-old male was referred from the Department
of Advanced Education in General Dentistry, School
of Dentistry, University of Michigan, for implant con-
sultation regarding tooth #25 in May 2009. Oral in-
formed consent to be profiled was obtained from the
patient prior to the commencement of treatment.
Medical history was significant for human immunode-
ficiency virus (HIV) infection (CD4 count and viral
load were 548/mL [normal CD4 count ranged from
500 to 1,000/mL] and <48 copies/mL, respectively).
In addition, white blood cell and red blood cell counts
were below the normal range (3.9 · 103/mm3 and
3.49 · 106 cells/mL, respectively). Antiviral medica-
tions included the combinations of lopinavir and
ritonavir‡ and lamivudine and zidovudine.§ Tooth
#25 had been treated endodontically several years
ago and had fractured 1 month prior. The tooth was
asymptomatic. A periapical radiograph showed in-
complete root canal treatment with apical radiolu-
cency (Fig. 1I). Because the tooth was non-restorable,
Table 1.
Review of Etiology of Implants Affected
by RPI
Probable etiology
Residual bacteria in implant site2,8-10
Adjacent endodontic lesion4,5,7,8
Violation of minimal distance from adjacent tooth8
Overheating2,3,8,10
Implant surface contamination6,10
Residual root particles or foreign bodies3,10
Surgical drilling beyond the length of the implant3
Fenestration of vestibular bone10
Bone compression10




Technique of the particular implant system used8
Bone loss caused by mucoperiosteal flap procedure8 ‡ Kaletra, Abbott Laboratories, Abbott Park, IL.
§ Combivir, ViiV Healthcare, Research Triangle Park, NC.
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ridge preservation with allografti covered with a colla-
gen plug¶ at the time of tooth extraction with delayed
single implant replacement was performed (Figs. 1A
through 1C and Fig. 1J). At the postoperative ap-
pointment, dislodgment of the collagen plug was
noted, with some allograft exfoliation on the surface
of the socket. No signs of infection were evident.
Four months after the ridge-preservation procedures,
a 3.25 · 13-mm implant# was placed in a one-stage
approach. The postoperative course of healing was
uneventful. Three months after implant placement,
a radiolucency measuring 4 mm in diameter was iden-
tified at the implant apex. A diagnosis of RPI (Fig. 1K)
was established. In subsequent follow-up visits, the
lesion demonstrated an increase in size, and conse-
quently surgical intervention was planned.
An incision was made at the mucogingival junction
and a periosteal flap was raised. The buccal plate
was removed to gain access to the lesion (Figs. 1D
through 1F). Apical fluid was collected with paper
points and processed using a commercially available
DNA test kit** to determine the presence of 11 path-
ogenic microbial species. The tested bacteria in-
cluded Aggregatibacter actinomycetemcomitans
(previously Actinobacillus actinomycetemcomitans),
Porphyromonas gingivalis, Tannerella forsythia (pre-
viously T. forsythensis), Treponema denticola, Pre-
votella intermedia, Parvimonas micra (previously
Peptostreptococcus micros), Fusobacterium nuclea-
tum, Campylobacter rectus, Cubacterium nodatum,
Eikenella corrodens, and Capnocytophaga species.
In addition, tissue was collected from the lesion
for a histopathologic examination. The bony de-
fect around the implant tip was irrigated with 0.12%
chlorhexidine gluconate†† and subsequently filled
with allograft‡‡ mixed with 250 mg tetracycline pow-
der and 0.9% normal saline (Fig. 1G). The flap was
approximated and sutured with 5-0 chromic gut.§§
The healing was uneventful and the implant was
restored 3 months after the surgery (Fig. 1H). At
a 6-month postoperative appointment, significant
radiographic resolution of the lesion was observed
(Fig. 1L).
Case 2
A 54-year-old female presented to the University of
Michigan School of Dentistry on October 8, 2009,
for implant placement in the tooth #12 area. The pa-
tient gave verbal consent to be profiled prior to treat-
ment. Her medical history included seasonal allergies
and rosacea. At the time of presentation, she was tak-
ing over-the-counter ibuprofen, acetaminophen, and
a nasal decongestant spray when necessary. The
patient reported that tooth #12 had been extracted
because of dental caries and had been missing for
>3 years. On March 12, 2010, a dental implantii (4
· 11 mm) was placed, uneventfully, in a one-stage ap-
proach. At 1-week postoperatively, moderate swell-
ing was noted in the apical area of teeth #12 and
#13. Percussion test was positive on tooth #13. How-
ever, a periapical radiograph of teeth #12 and #13
showed no abnormalities. The patient was placed
on amoxicillin, 500 mg three times daily, for 7 days
and referred for endodontic evaluation on tooth
#13. Subsequently, endodontic therapy on tooth
#13 was completed on April 16, 2010. A radiograph
of the area revealed a peri-implant radiolucency local-
ized to the apex of tooth #12, and surgical intervention
to correct the lesion was initiated (Fig. 2). On clinical
examination of the implant, no mobility was noted. An
incision was made at the mucogingival junction and
a full-thickness flap was reflected. There was no buc-
cal plate found covering the RPI lesion. Fluid and
paper point samples were obtained from the apical
lesion and sent for microbial testing as described pre-
viously. In addition, soft tissue from the lesion was re-
moved for histopathologic examination. The apical
bony defect was degranulated and cortical bone
allograft¶¶ with a bioabsorbable membrane## was
placed over the defect. The flap was repositioned
and sutured with 4-0 chromic gut sutures.*** At the
2-week postoperative appointment, it was noted that
healing was within normal limits. Three months after
the surgery, the implant was restored (Fig. 2F), and
at 6 months periapical radiographs demonstrated res-
olution of the lesion (Fig. 2H).
Microbial Test Results
The microbial test of Case 1 failed to detect any ex-
amined bacterial species. Histopathologically (Fig.
3A), the specimen consisted of fibrous connective
tissue with a mild chronic mixed inflammatory cell in-
filtrate. Viable bone was noted at the periphery of the
specimen. At higher magnification (Fig. 3B), clusters
of inflammatory cells, primarily lymphocytes, were
noted in a background of relatively dense connective
tissue.
In Case 2, the bacterial test revealed increased
numbers of E. corrodens. Histopathologically, nu-
merous acute and chronic inflammatory cells could
be seen in a background of immature granulation tis-
sue containing numerous small- to medium-diameter
blood vessels (Fig. 3C). At higher magnification (Fig.
i Puros Cortical Particulate Allograft, Zimmer Dental, Carlsbad, CA.
¶ CollaPlug, Zimmer Dental.
# 3i NanoTite Tapered, Biomet 3i, Warshaw, IN.
** Micro-IDent plus, Hain Diagnostics, Midland, TX.
†† Peridex, 3M, St. Paul, MN.
‡‡ Puros Cortical Particulate Allograft, Zimmer Dental.
§§ Ethicon, Johnson & Johnson, Somerville, NJ.
ii AstraTech Osseospeed Straight, Molndal, Sweden.
¶¶ Puros Cortical Particulate Allograft, Zimmer Dental.
## Biomend, Zimmer Dental.
*** Ethicon, Johnson & Johnson.
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3D), collections of neutrophils,
macrophages, and lymphocytes
were noted within the loose vas-
cular connective tissue.
DISCUSSION
Possible Role of HIV Infection
in RPI
The delayed or non-union of
bone fractures in HIV patients,
caused by impaired wound
healing, is well recognized13 and
several mechanisms have been
proposed.14 The virus is known
to alter the rate of bone resorp-
tion and formation.14 It is spec-
ulated that the mechanism
involves the modulation of the
tumor necrosis factor-a super-
family, including the receptor
activator nuclear factor-kappa
B ligand and osteoprotegerin,
by HIV.15 Osteocalcin is reduced
in the serum of patients with HIV
although the precise function
of osteocalcin was not fully elu-
cidated.16 The deregulation of
various systemic cytokines that
occurs in patients who are
HIV-positive may disrupt bone
homeostasis.17 HIV infection
may also compromise microcir-
culation and thus affect bone
healing.18
There is currently a lack of
evidence regarding the inci-
dence of implant complications
in patients who are HIV-positive
compared to healthy patients.19
Based on the fact that bone
healing might be impaired by
HIV infection, through the afore-
mentioned mechanisms, dental
implant healing might also be
affected in HIV-active or AIDS
patients. To the best of our
knowledge, this is the first article
to report the possible associa-
tion between HIV infection and
RPI. In this case, when the ex-
traction socket was thoroughly
debrided and socket augmen-
tation procedure was perform-
ed, little bleeding was noted
during the procedure, suggest-
ing impaired microcirculation.
Figure 1.
Case 1. Unrestorable tooth #25 with apical radiolucency. Extraction, socket preservation, and delayed
implant placement were performed (A through C, I, and J). Apical lesion at the implant was revealed
(K), and surgical debridement and bone grafting were performed (D through G). There was
uneventful healing (H), and the x-ray showed increased density (L).
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At the postoperative follow-up appointment, the
socket was exposed without full soft-tissue cover-
age and the coronal part of bone graft had dislodged,
indicative of unfavorable healing. Histology of the RPI
lesion showed significant soft-tissue encroachment,
suggestive of impaired bone formation at the im-
plant apex. As a result, the pos-
sible role of HIV infection on
the development of RPI cannot
be ruled out.
Possible Association Between
Endodontic Lesions and RPI
Most case reports (Table 1)
suggest that residual bacteria
in a radiographically healed
socket or in an adjacent peri-
apical lesion are the main
cause of RPI. It was further sug-
gested that endodontic bacteria
can be reactivated during im-
plant osteotomy, leading to
implant infection.2,10 In both
of these cases, microbial ex-
amination was used to detect
the presence of 11 pathogenic
bacterial species in the apical
lesion of the affected implants.
To the best of our knowledge,
this was the first time that a
culture-independent microbial
examination was applied for
the detection of RPI-associated
bacteria. This kit was primarily
designed for the detection
of periodontal pathogens. We
used this technique to screen
for the presence of microbial
pathogens associated with
the apical lesions in this study
because some of these 11 spe-
cies are also associated with
periapical pathosis.20-22 The
number of E. corrodens was
found to be elevated in Case
2, suggesting a possible as-
sociation with the develop-
ment of RPI. The fact that
this specific species is com-
monly found in endodontic
lesions suggests that the en-
dodontic lesion from adjacent
teeth may be a factor in the
development of RPI. The evi-
dence would have been more
convincing if this species was
also detected at the adjacent infected root apex.
Treatment of RPI
Table 2 provides a summary of the available litera-
ture on the management of RPI.2,5,7,9,23-28 Various
techniques were used, such as debridement only
or the combination of debridement with grafting
Figure 2.
Case 2. A) Persistent swelling associated with a recently placed #12 implant. B through E) Surgical
intervention was executed with a guided bone regeneration technique; F) the healing was uneventful.
Radiograph revealed a well-defined radiolucent lesion at the implant apex corresponding with the
swelling. G) Tooth #13 during endodontic therapy. H) Radiograph showed normal bone density after
the crown was delivered.
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material with or without membrane, detoxification of
infected implant surfaces, or apicoectomy. The treat-
ment goals of RPI include the elimination of infection,
resolution of the lesion, and ultimately implant sur-
vival. Our proposed decision-making flowchart
(Fig. 4) for the treatment of RPI requires identifica-
tion of the most likely etiology. Vitality testing and ra-
diographic examination on neighboring teeth are
required because in most case reports, the lesion
has been linked to apical pathology from adjacent
teeth. Simultaneously, the stability of the affected
implant needs to be assessed. If the infected im-
plant is mobile, it should be removed and the
socket thoroughly debrided.29 The socket can be ei-
ther grafted for later implant placement30,31 or it can
receive a wider or longer implant after the removal of
the mobile implant.32 Generally, a staged approach
is preferred unless elimination of the etiologic causa-
tive factors is certain. Systemic antibiotics alone are
not able to abate the signs and symptoms.23,27 Al-
ternatively, a surgical approach combined with sys-
temic antibiotics may resolve the lesion provided
the implant is not mobile.2,5,9,23-27
The literature supports a sur-
gical approach that may include
only debridement4,9 or bone
replacement grafts (BRGs) with
or without the use of membrane
barriers.2,4,5,27 The use of dif-
ferent types of BRGs with or
without occlusive membranes
is not universally accepted;
however, their application may
provide several advantages.
First, BRGs can act as a scaffold
for new bone cells to grow into
the bony defect. Second, they
can maintain the space and
prevent soft tissue from repopu-
lating the defect. It has been
demonstrated that the use of
bone regeneration materials for
apicoectomy surgeries improves
the predictability of clinical, ra-
diographic, and histologic heal-
ing.33 Studies also suggest that
the initial defect size adversely
influences tissue healing after
apicoectomy procedures, with
defects £5 mm showing better
healing.34,35
Four types of BRGs are
available. The autogenous bone
graft is considered the gold
standard because it possesses
osteogenic properties. Never-
theless, their limited availability and the potential
for donor site morbidity reduce their usefulness. Al-
lografts, such as freeze-dried bone graft or deminer-
alized freeze-dried bone graft, overcome some of
the potential limitations of autogenous bone grafting.
Periodontal regeneration induced by demineralized
freeze-dried bone graft, including the formation of
new bone, cementum, and periodontal ligament
fibers, has been documented in a human histology
study.36 Freeze-dried bone allograft has been suc-
cessfully used in apical lesions associated with failed
endodontic treatment.37 Xenografts, most com-
monly from bovine bone, provide similar properties
to allograft materials. Alloplasts, acting as fillers,
result in tissue repair rather than regeneration.38
To achieve more predictable bone regeneration,
BRGs, except alloplasts, can be used for treating
RPI.38
The concept of guided tissue regeneration based
on Melcher’s conceptual article39 uses barrier
membranes to differentiate cell growth. When applied
in periapical surgeries, it has been demonstrated to
yield good results in terms of shortening the healing
Figure 3.
Histopathology (hematoxylin and eosin stain) of the two RPI cases. Case 1: A) At lower magnification
(·10), fibrous connective tissue with a mild, chronic, mixed inflammatory cell infiltrate was noticed.
B) At higher magnification (·20), clusters of lymphocytes were in a background of relatively dense
connective tissue. Case 2: C) Lower magnification (·20) showed numerous acute and chronic
inflammator y cells with immature granulation tissue. D) At higher magnification (·60),
collections of neutrophils, macrophages, lymphocytes, and engorged blood vessels were noted.
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time and increasing the amount of bone fill.40,41 Be-
cause healing is less favorable in large periapical
defects,34,35 the application of occlusive membrane
might be beneficial in these situations.
Reosseointegration requires implant surface de-
toxification and the application of chemotherapeutic
agents, such as tetracycline, chlorhexidine gluconate,
and citric acid.29 One animal study investigated four
methods: 1) air-powder abrasive unit and citric acid,
2) air-powder abrasive unit only, 3) gauze soaked in
saline and citric acid, and 4) gauze soaked alternately
in chlorhexidine and saline for surface treatment of
peri-implantitis.42 The degree of reosseointegration
varies greatly,43 and does not seem to differ among
these methods. Because no one method has proved
to be distinctly superior, chemical agents or air abra-
sives may be used.44
Implant apicoectomy has been thoroughly covered
in many case reports.5,23,27 Although Ayangco and
Sheridan9 suggested that scratching of the implant
surface in such a location might not be crucial, Ataullah
et al.25 suggested that surface debridement be carried
out with extreme care to prevent damage to the sur-
face of the fixture. Practically, if the affected implant
prevents thorough and complete debridement, it can
be sectioned.30
CONCLUSIONS
A decision-making flowchart for the treatment of
RPI was proposed based on review of currently
available relevant literature. Bacterial contami-
nation from endodontic lesions as an important
etiologic factor was further strengthened by the
presence of E. corrodens revealed by a DNA-based
microbial test in this article. Further research should
concentrate on the role of compromised systemic
health on RPI and the investigation of the effective-
ness of different surgical modalities for the treat-
ment of RPI.
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Table 2.
Review of the Treatment Approaches for Implants With RPI
Reference Cases (n) Grafting Material Membrane Detoxification Apicoectomy
McAllister et al.2 2 Allograft No Tetracycline No
Allograft Copolymer Tetracycline No
Bretz et al.28 1 Allograft No Chlorhexidine No
Shaffer et al.5 2 Allograft Copolymer No Yes
No No No Yes
Ayangco and Sheridan9 3 No No Tetracycline No
No No Tetracycline No
No No Tetracycline No
Brisman et al.7 1 No No No No
Jalbout and Tarnow27 4 Xenograft Collagen No Yes
Xenograft Copolymer No No
Allograft No No No
Alloplast No No No
Flanagan26 1 Calcium hydroxide paste No No No
Ataullah et al.25 1 Xenograft Collagen Chlorhexidine No
Tozum et al.24 1 Calcium sulfate Collagen No No
Dahlin et al.23 2 No No No Yes
No No No Yes
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